Click to enquire

A Case for Local Pharmaceutical Manufacturing in Africa in Light of the COVID-19 Pandemic

15th July 2020

The successful experience of industrialized nations proves that health systems, when coordinated with technological development, can also generate goods and services that are crucial for economic development. Like many low- and middle-income countries, sub-Saharan African nations also aspire to develop their pharmaceutical industry by promoting access to affordable quality medicine. Many countries are taking restrictive measures during the current Covid-19 pandemic to secure adequate access to medical products. The lockdown in China and India due to the Covid-19 pandemic has resulted in a huge market gap. Against such a backdrop, this paper will discuss the issue of scaling up the local pharmaceutical production in Africa as an opportunity, as well as a necessity, to tackle local epidemics and non-communicable diseases whose control could be undermined by the scale of the Covid-19 outbreak.